MedPath

Shanghai Jiaotong Medical University Attached Ruijin Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts

Phase 1
Conditions
Close Contact Transmission
Interventions
First Posted Date
2022-06-13
Last Posted Date
2022-06-13
Lead Sponsor
Ruijin Hospital
Target Recruit Count
60
Registration Number
NCT05415241

Effect of a Self-designed MET Exercise Intervention on Cancer-related Fatigue in Patients With Gastric Cancer

Not Applicable
Completed
Conditions
Neoplasm of Stomach
Interventions
Behavioral: Met exercises
First Posted Date
2022-06-02
Last Posted Date
2023-12-21
Lead Sponsor
Ruijin Hospital
Target Recruit Count
119
Registration Number
NCT05401045
Locations
🇨🇳

Ruijin Hospital, Shanghai, Shanghai, China

Asymmetric Targeted DBS for PD With PIGD

Not Applicable
Recruiting
Conditions
Parkinson Disease
Interventions
Device: Deep brain stimulation
First Posted Date
2022-05-31
Last Posted Date
2023-01-23
Lead Sponsor
Ruijin Hospital
Target Recruit Count
40
Registration Number
NCT05397340
Locations
🇨🇳

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

A Follow-up Study of Asymptomatic Infections and Diagnosed Patients With Covid-19 in Shanghai

Recruiting
Conditions
COVID-19
First Posted Date
2022-05-24
Last Posted Date
2022-05-24
Lead Sponsor
Ruijin Hospital
Target Recruit Count
250000
Registration Number
NCT05387304
Locations
🇨🇳

Ruijin Hospital, Shanghai, China

Paxlovid in the Treatment of COVID-19 Patients With Uremia

Early Phase 1
Conditions
COVID-19
Uremia
Interventions
Drug: standard-of-care
Drug: Paxlovid
First Posted Date
2022-05-23
Last Posted Date
2022-05-23
Lead Sponsor
Ruijin Hospital
Target Recruit Count
40
Registration Number
NCT05386433

Phacoemulsification Combined With Intravitreal Injection of Ranibizumab Prevent Postoperative Capillary Non-perfusion Zone Progress in Non-proliferative Diabetic Retinopathy

Phase 4
Conditions
Diabetic Retinopathy
Mild Non-proliferative Diabetic Retinopathy
Cataract Diabetic
Interventions
Device: Phacoemulsification
First Posted Date
2022-05-23
Last Posted Date
2022-05-23
Lead Sponsor
Ruijin Hospital
Target Recruit Count
96
Registration Number
NCT05386160
Locations
🇨🇳

Department of Ophthalmology, Ruijin Hospital Affiliated Medical,Shanghai Jiaotong University School, Shanghai, Shanghai, China

Bortezomib for Treating Glomerular Diseases

Not Applicable
Conditions
MN
Bortezomib
Glomerulonephritis
MPGN
FSGS
IgA Nephropathy
Interventions
First Posted Date
2022-05-20
Last Posted Date
2022-10-31
Lead Sponsor
Ruijin Hospital
Target Recruit Count
20
Registration Number
NCT05383547
Locations
🇨🇳

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

PSA Versus STN DBS for TD-PD

Not Applicable
Recruiting
Conditions
Parkinson Disease
Interventions
Device: Deep brain stimulation
First Posted Date
2022-05-19
Last Posted Date
2025-04-09
Lead Sponsor
Ruijin Hospital
Target Recruit Count
30
Registration Number
NCT05382858
Locations
🇨🇳

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

Povidone Iodine Nasal Irrigation and Gargling to Reduce Viral Load in Asymptomatic Patients With COVID-19

Not Applicable
Conditions
2019 Novel Coronavirus Infection
Interventions
Other: PVP-I Nasal Irrigation and gargling
First Posted Date
2022-05-17
Last Posted Date
2022-05-24
Lead Sponsor
Ruijin Hospital
Target Recruit Count
300
Registration Number
NCT05375773
Locations
🇨🇳

Ruijin Hospital,Shanghai Jiaotong University school of medicine, Shanghai, Shanghai, China

Epidemiological Study on Asymptomatic Infections and Mild Illness With Covid-19 in Shanghai

Conditions
COVID-19
Interventions
Biological: Vaccination completion status
First Posted Date
2022-05-17
Last Posted Date
2022-05-17
Lead Sponsor
Ruijin Hospital
Target Recruit Count
10000
Registration Number
NCT05375786
Locations
🇨🇳

Ruijin hospital, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath